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ARTICLE
Engineered CRISPRa enables programmable
eukaryote-like gene activation in bacteria
Yang Liu1,2, Xinyi Wan1,2 & Baojun Wang 1,2
Transcriptional regulation by nuclease-deﬁcient CRISPR/Cas is a popular and valuable tool
for routine control of gene expression. CRISPR interference in bacteria can be reliably
achieved with high efﬁciencies. Yet, options for CRISPR activation (CRISPRa) remained
limited in ﬂexibility and activity because they relied on σ70 promoters. Here we report a
eukaryote-like bacterial CRISPRa system based on σ54-dependent promoters, which supports
long distance, and hence multi-input regulation with high dynamic ranges. Our CRISPRa
device can activate σ54-dependent promoters with biotechnology relevance in non-model
bacteria. It also supports orthogonal gene regulation on multiple levels. Combining our
CRISPRa with dxCas9 further expands ﬂexibility in DNA targeting, and boosts dynamic
ranges into regimes that enable construction of cascaded CRISPRa circuits. Application-wise,
we construct a reusable scanning platform for readily optimizing metabolic pathways without
library reconstructions. This eukaryote-like CRISPRa system is therefore a powerful and
versatile synthetic biology tool for diverse research and industrial applications.
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In recent years, reprogrammable CRISPR (Clustered RegularlyInterspaced Short Palindromic Repeats)-mediated geneticregulation has emerged as a powerful tool for synthetic biology
research. Transcriptional regulations through CRISPR inter-
ference (CRISPRi) and activation (CRISPRa) were widely used to
modulate gene expression1–10. Bacterial CRISPRi is a matured
technology with plenty of examples but for bacterial CRISPRa,
few have been demonstrated2,10. The established mechanisms
have RNA polymerase-recruiting domains linked to a
dCas9–sgRNA complex, and rely on direct interactions between
the complex and a σ70 promoter. These designs suffered from low
dynamic ranges of activation output and could not support multi-
input activation because the operator must lie near the core
promoter regions, and the σ70 promoter per se must be weak
enough for activation to be observed10.
In contrast, σ54-dependent promoters were much overlooked
potential targets for CRISPRa. A σ54 factor “locks” a σ54-depen-
dent promoter in a stable closed complex that tightly blocks
transcription initiation11,12. A σ54-activator binds to an upstream
activating sequence (UAS) and performs long-distance regulation
through a local DNA loop, and catalyzes ATP hydrolysis to
unlock the complex for transcription initiation. This mechanism
is similar to transcriptional activation involving the eukaryotic
RNA polymerase II in several ways and is known as “eukaryote-
like” regulation in bacteria13–18. Hence, σ54-activators are often
termed “bacterial Enhancer Binding Proteins” (bEBPs)18,19.
Here, we construct and characterize a CRISPRa system based
on a eukaryote-like activation mechanism in bacteria. This
CRISPRa device shows strong activity, superior dynamic range
(ON–OFF dynamic range > 1000 and > 70-fold between cognate
and mismatch sgRNA) and remarkable tolerance to a wide range
of UAS locations. The device can work in both Escherichia coli
and non-model bacteria, and can activate multiple high value
wild-type (WT) σ54-dependent promoters. Use of dxCas9 enables
non-canonical PAM targeting and further improves the dynamic
ranges of the system to practical application-required levels.
Finally, we set up an efﬁcient proﬁle scanning platform for
metabolic pathways, in which the sgRNA library and thus its
encoded transcriptional activation proﬁles do not need to be
rebuilt and can be applied to different pathways. Those proﬁles,
when applied to multi-gene expression, show good stability and
durability. This CRISPRa device not only enriches the genetic
regulation toolbox, but also supports real-life application sce-
narios by its high performance.
Results
Design of eukaryote-like CRISPR activation in bacteria. To
build a eukaryote-like programmable activation system, our ﬁrst
step was to identify a functional σ54-activation domain. It has
been proven that the bEBP PspF from E. coli has a highly
modular structure—a truncated PspF remained as a functional
activation domain in a three-hybrid system in vitro20,21. A similar
strategy was adopted to bridge the sgRNA and the activator—an
RNA-binding peptide λN22plus was fused to the PspF activation
domain (PspFΔHTH) at the C-terminus to create PspFΔHTH::
λN22plus. We designed the sgRNA scaffold to incorporate two
BoxB RNA aptamers, which recruit λN22plus peptide fused
proteins, at the Tetra-loop and the stem loop 2 (Fig. 1b)22,23. To
optimize sgRNA scaffold, we also mutated the U-A pair to G-C at
“+5”23. We then set up a test platform using the σ54-dependent
PpspA promoter. In total, 3 bp downstream of the native UAS were
mutated to an NGG PAM, which could be targeted by a
dCas9–sgRNA complex. A sfGFP reporter was placed down-
stream to monitor the transcriptional output (Fig. 1a). We ver-
iﬁed that this promoter could still be activated by its cognate
activator PspF in E. coli MC1061ΔpspF (Fig. 1e). These compo-
nents, when supplemented by dCas9 and transformed into E. coli,
successfully generated a transcriptional activation response
similar to that of wild-type PspF, demonstrating the proof-of-
concept of our CRISPRa system on σ54-dependent promoters
(Fig. 1e). We then generated another UAS-gRNA set by replacing
the UAS of PpspA by two copies of UAS (G6) from the PhrpL
promoter and modiﬁed the sgRNA correspondingly. A combi-
natorial activation test showed that the σ54-dependent promoters
could only be activated when the UAS sequence matched the
sequence of the spacer region in the sgRNA (Fig. 1e), proving that
our CRISPRa system critically relied on sgRNA-UAS speciﬁcity
and had little cross-talk issues.
Given that many CRISPRa systems in eukaryotes were built by
fusing the activation domain to dCas9 directly3,5, we asked if the
same could be applied to the PspF activation domain. The HTH
domain truncated PspF was fused to dCas9 and CRISPRa was
attempted, but was unsuccessful (Supplementary Fig. 1c). This
result was within expectation given that PspF must assemble as a
hexamer to function, and dCas9 probably interfered with the
assembly process as it was relatively bulky24,25.
To demonstrate the necessity of dCas9, sgRNA, PspFΔHTH::
λN22plus (or simply, activator) and the σ54 factor (RpoN) in our
CRISPRa system, we constructed reporter circuits with or without
the dCas9 generator, the sgRNA generator and the activator
generator circuits on three different plasmids. These plasmids
were combinatorially mixed with empty vector controls and co-
transformed into cells. A strong response could only be achieved
when all three components were present, with a dynamic range of
78-fold between the cognate and the mismatched sgRNA (Fig. 1c).
Therefore, our CRISPRa activity can be controlled and tuned on
three dimensions. This CRISPRa device was non-functional in a
ΔrpoN strain and thus is σ54-dependent (Supplementary Fig. 1e).
Regarding the requirement of hexamer assembly of the activator,
we further asked if only one UAS would sufﬁce to stabilize
hexamer assembly, by providing only two instead of four RNA
aptamers that act as local docking sites for activators. Our results
show that a single UAS remains functional in its activity
(Supplementary Fig. 1a).
One of our goals was to create a CRISPRa system that does not
depend on the host strain, so the CRISPRa that successfully
worked in MC1061ΔpspF was transformed into and tested in a
general cloning strain E. coli TOP10. The dynamic range was
similar to that in MC1061ΔpspF but the maximum activity was
halved (Supplementary Fig. 2). We reasoned that it might be due
to potential background expression of the endogenous PspA
protein controlled by PpspA promoter on the genome, which is
known to allosterically inhibit PspF20,26. This hypothesis was
indirectly supported by the observation that expression of
PspFΔHTH::λN22plus (without sgRNA for CRISPRa) led to a
higher activation efﬁciency on wild-type PpspA in TOP10 than in
MC1061ΔpspF (Supplementary Fig. 1f). As the engineered
PspFΔHTH::λN22plus has no DNA binding domain to target
PpspA on the genome, it was likely that the endogenous PspA
expression was activated by heterohexamers comprising
PspFΔHTH::λN22plus and PspF and increased levels of PspA
in turn impaired the efﬁciency of the activator on our engineered
promoter in TOP10. It is worthwhile to mention that the lower
output level in TOP10 may also be caused by other unknown
mechanisms.
Nonetheless, our CRISPRa system still retained signiﬁcant
activity for general purposes. The rest of this study, except for
those in Fig. 3d (see below), were done in the strain
MC1061ΔpspF as it provided a higher maximum output so small
changes in activities could be readily detected. In addition, to
simplify our system for further optimizations, we put the
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activator under the control of a constitutive Anderson promoter
BBa_J2310627, which provided the best output function com-
pared to three other promoters of different strengths tested
(Supplementary Fig. 1b).
Optimization of target sites and sgRNA based dynamic ranges.
Successful activation of the σ54-dependent promoter critically
depends on its local DNA loop structure, which establishes a two-
dimensional spatial relationship between the UAS and the tran-
scription start site. This means that the spatial direction of the
engineered activator relative to the axis of the DNA helix may
affect the efﬁciency of our CRISPRa system (Fig. 2a). To under-
stand the relationship between UAS positions and the spatial
directions of the engineered PspF hexamer, we designed a library
of PpspA where the synthetic UAS was progressively shifted
upstream from its original location (deﬁned as “0”), and mea-
sured the resulting efﬁcacies of CRISPRa. CRISPRa remained
functional within a shift window of 40 bp. Most interestingly, the
activities alternated between crests and troughs spaced at 5 bp
apart. This oscillation exactly matches the fact that the DNA helix
completes a turn every 10 bp (Fig. 2a), and strongly suggested a
phase-dependency between the UAS and the core promoter. We
thus sought further evidences and augmented the library to zoom
into the 0–10 bp region corresponding to half a wave length, and
indeed observed a sinusoidal waveform. This might provide
insights on the underlying molecular mechanism of our CRISPRa
system.
In our CRISPRa output characterization, the metric dynamic
range could be deﬁned in different ways depending on what
constitutes the OFF state. Our CRISPRa system achieved > 1000-
fold dynamic range for all component induced versus
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Fig. 1 Design and function of eukaryote-like CRISPR activation in E. coli. a The circuit design and structure of the CRISPRa device. The circuit includes a
sgRNA generator driven by Plux2 (light blue block, inducible by AHL), a dCas9 generator driven by Ptet (blue block, inducible by aTc), an activator generator
driven by PrhaB (red block, inducible by rhamnose), and a sfGFP reporter driven by PpspA with wild-type or heterologous UAS. b The activation mechanism of
a eukaryote-like long distance regulation in our CRISPRa design, based on the IHF-dependent DNA loop structure. c, d Test of necessity of the three
components in CRISPRa. c Combinations of components were achieved via presence (+) or absence (ø) of genetic part in the strain. The mismatch sgRNA
had a random sequence as its spacer (sgRNA-LEA3). All strains were cultured with AHL (1.6 µM), rhamnose (0.4 mM) and aTc (2.5 ng mL−1). Statistical
difference was determined by a two-tailed Welch’s t-test: (sgRNA cognate/mismatch) p= 0.0002, t= 74.98. d All genetic components for CRISPRa were
present in the strain and combinations were achieved via presence (+) or absence (−) of inducers. Inducer concentrations: AHL (1.6 µM), rhamnose
(0.4 mM) and aTc (2.5 ng mL−1). Statistical difference was determined by a two-tailed Welch’s t test: (+++/−−−), p= 0.0014, t= 26.82, (+++/−+−),
p= 0.0015, t= 25.98. e A PAM inserted PpspA with wild-type UAS (referred as mut) or heterologous UAS (referred as G6) was tested against different
spacers for activation in a pspF knocked out strain E. coli MC1061ΔpspF. Concentrations of inducers: aTc (2.5 ngmL−1), AHL (1.6 µM). Error bars, s.d. (n=
3); a.u., arbitrary units; p value summary: ****p value < 0.0001, 0.0001 < ***p value < 0.001, 0.001 < **p value < 0.01, 0.01 < *p value < 0.05, p value≥ 0.05:
n.s. Source data are provided as a Source Data ﬁle
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non-induced (Supplementary Fig. 3a), > 70-fold for cognate
versus mismatch sgRNA (Fig. 1c), and > 30-fold in the scenario
where dCas9 and sgRNA were treated as a single inducible unit
(Fig. 1d). These values surpassed the highest records to date10.
However, these values are not practically relevant when CRISPRa
needs to be applied to multi-gene regulation and transcriptional
cascades, where dCas9 and the activator should be constantly
available at a ﬁxed level and the sgRNA circuits need to be pre-
installed. Under this scenario, dynamic ranges are strictly deﬁned
by circuit outputs between sgRNA induced and sgRNA
uninduced states. Our results indicated that leaky sgRNA
transcription owing to a leaky inducible promoter activation
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Fig. 2 Optimization on synthetic UAS sites and sgRNA-dependent dynamic ranges. a Spatial relationship between the activator and the core PpspA with an
artiﬁcial UAS LEB2 (Supplementary Data 1). Activator was driven by the constitutive promoter BBa_J23106. Concentrations of inducers used in the ON
state: 0.4 µM AHL (sgRNA) and aTc 2.5 ngmL−1 (dCas9). No inducers were added in the OFF state. b sgRNA-dependent dynamic range optimization by
“Buffer Terminators” which were previously characterized59. c sgRNA-dependent dynamic range optimization by mismatches on the sgRNA scaffold.
d sgRNA-dependent dynamic range optimization by moving RNA aptamer to different positions. The ﬁrst three designs contained a wild-type U-A pair at
the “+5” site. The circuits for b–d all employed PpspA with two synthetic UAS LEA2 (Supplementary Data 1) and the activator was driven by the constitutive
promoter BBa_J23106. Concentrations of inducers used: 0.4 µM AHL (sgRNA) and aTc 2.5 ng mL−1 (dCas9). Error bars, s.d. (n= 3); a.u., arbitrary units.
Source data are provided as a Source Data ﬁle
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explained the signiﬁcant basal activation observed in the
inducible device (Fig. 1c, d). To optimize the CRISPRa system
and improve its dynamic ranges (deﬁned by induced versus non-
induced sgRNA), we ﬁrst investigated its input–output relation-
ship, and discovered that low induction levels for sgRNA already
led to saturated CRISPRa responses (Supplementary Fig. 4).
Therefore, we reasoned that a decrease in the range of sgRNA
input, either by reducing sgRNA induction efﬁciencies or by
reducing sgRNA’s afﬁnities to dCas9, would decrease the
leakiness of CRISPRa, whereas excessive sgRNA would maintain
its maximum output. To this end, we explored three separate
strategies in optimizing sgRNA-dependent dynamic ranges. First,
we inserted various known terminators as buffer sequence
(named as “buffer terminators”) between Plux2 and sgRNA to
interfere the function of the promoter and the output ranges of
sgRNA transcription. Some of them reduced sgRNA leakiness
and signiﬁcantly improved the dynamic ranges to >10-fold
(Fig. 2b). Second, we employed a wild-type U-A pair at the “+5”
site and introduced no, one or two nucleotide mismatches into
the original sgRNA scaffold, and hypothesized a reduction in the
resulting dCas9–sgRNA afﬁnity. sgRNA with two mismatching
nucleotides could increase the dynamic range signiﬁcantly to ~
10-fold (Fig. 2c). Third, we moved the RNA aptamers onto
different positions of the sgRNA scaffold, but discovered that our
initial design was both necessary and sufﬁcient (Fig. 2d). We
further applied our ﬁrst and second strategies to different spacers
and the “mismatch in sgRNA strategy” was generally more
versatile (Supplementary Fig. 5).
CRISPRa is functional on different σ54-dependent promoters.
Our success in swapping the wild-type UAS in mutant PpspA with
an orthogonal UAS suggested that our CRISPRa system could be
repurposed to activate any σ54-dependent promoters, provided
that a PAM could be found near the native UAS. This would be
immensely useful for studying σ54-dependent promoters, because
unlike PspF, many σ54-activators from bacteria are response
regulators for environmental stimuli28. Thus, activation of their
cognate promoters could be hardly achieved without changing the
culture condition, which inevitably introduces additional factors
in an experiment.
To demonstrate the function of our CRISPRa system on σ54-
dependent promoters, we identiﬁed and cloned several promoters
with research relevance: The wild-type PpspA promoter was
involved in phage shock response. PhrpL from Pseudomonas
syringae regulates Type III Secretion System-mediated patho-
genicity in plants29, and promoters PnifH and PnifJ control a
nitrogen ﬁxation pathway in Klebsiella oxytoca that responds to
nitrogen and oxygen availabilities30. For these promoters, we
intended to maintain sequence integrity, so we opted for PAM
sites near the wild-type UAS instead of inserting new ones. All
promoters could be successfully activated by our CRISPRa system
to drive sfGFP expression (Fig. 3a). We further asked if our
CRISPRa system could activate endogenous σ54-dependent
promoters on E. coli genome, rather than just episomes. We
targeted pspA in MC1061ΔpspF for activation and employed RT-
qPCR to measure the relative transcription activities from PpspA
and PnorVW, and results showed that the former was activated in a
speciﬁc manner (Supplementary Fig. 6).
We also demonstrated that the CRISPRa systems with
engineered PspFΔHTH::λN22plus built for PnifH and PnifJ were
functional when transferred to the original host species K. oxytoca
(Fig. 3b), proving that our CRISPRa system could be hetero-
logously expressed to activate σ54-dependent promoters in other
species. This should be helpful for bypassing their natural genetic
regulatory networks31.
It is worth mentioning that the relative activation efﬁciencies
on wild-type σ54-dependent promoters by the CRISPRa system
versus efﬁciencies mediated by their wild-type cognate activators
has no ﬁxed value even when the transcription levels of the
activator genes were similar (Supplementary Fig. 7). This might
be affected by the differences in targeting afﬁnities between the
CRISPRa complexes and their wild-type cognate activators and
suboptimal UAS sequences owing to limitations in the availability
of NGG PAM positions on the wild-type promoters.
As an example of utilizing this CRISPRa as a tool for σ54-
dependent promoter related research, we employed our CRISPRa
system to research potential modularity of the DNA components
within a σ54-dependent promoter. σ54-dependent promoters are
diverse in structures, with different UAS (in strength and
numbers), loop regions, and core sequences32,33. Based on
consensus sequences, we standardized, in length, three DNA
loop regions and three core sequences from different σ54-
dependent promoters. We then connected them combinatorially,
with identical linker DNA in between, and placed them
downstream of a synthetic UAS (Fig. 3c). Our results showed
that except for the PﬂhDp2 core sequence, DNA loop regions and
core sequences are modular and could be shufﬂed to yield
functional hybrid promoters (Supplementary Fig. 8). In addition,
the relative ranks of dynamic ranges conferred by one core
sequence is consistent when paired with different loop regions.
This is also true when the same loop region is pair with different
core sequences. So the PhrpL loop region and the PpspA core
sequence, which were consistently the strongest when paired with
different elements, could combine to give a hybrid promoter with
the highest dynamic range (Fig. 3c).
Alternative σ54-activator mining by protein engineering. To
minimize the inﬂuence of the host strain on our CRISPRa system
owing to potential PspFΔHTH::λN22plus/PspF heterohexamers
formation, we searched for other σ54-activators, which might be
orthogonal to the PspF-based activator. This however posed a
challenge, because many bEBPs contain a sensory module
domain at their N-termini, which must be removed to avoid
interference from their regulatory pathways in the host28.
One such example is the bEBP NorR from E. coli, involved in
NO sensing34,35. NorR with its sensory module deleted (NorRΔ-
GAF) strongly activates its cognate promoter PnorV in absence of
NO36,37. We thus replaced the HTH domain in NorRΔGAF by
λN22plus as we did for PspF and tested its activation function, but
no signiﬁcant activity was observed. Previous researches indicate
that for two bEBPs, HrpS, and HrpR, the HTH domain may be
required for assembly into the HrpRS hexamer29. We conjectured
that the same applied to NorR, and so generated two constructs
with most of the NorRΔGAF fused directly to the λN22plus
peptide, which successfully yielded activities in CRISPRa (Fig. 3d).
Subsequently, we tested three other bEBPs using the same
approach, and identiﬁed a new functional activator based on
WtsA, which regulates expression of pathogenic genes in Erwinia
stewartii38 (Fig. 3d, Supplementary Fig. 10). Unlike NorRΔGAF::
λN22plus, WtsA::λN22plus did not impose signiﬁcant metabolic
burden onto E. coli (Supplementary Fig. 9).
Orthogonality based on gRNA and UAS. Orthogonality is a
prerequisite for multiplex gene regulation39,40. Our CRISPRa
comprises multiple components and thus offered opportunities to
engineer orthogonality on different levels. We ﬁrst capitalized on
the speciﬁcity between UAS and gRNA (Fig. 1e) to create a library
of orthogonal UAS-gRNA pairs. We designed a library of syn-
thetic PpspA and generated unique UAS by sequence randomiza-
tion. Based on the functional window for UAS locations (Fig. 2a),
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we designed two synthetic enhancers with PAM at −108 to −110
(LEB) and at −128 to −130 (LEA) respectively. The 10 sgRNA
generators with the 5 CRISPRa circuits carrying various UAS
were co-transformed and tested for activation. The results con-
ﬁrmed that the synthetic PpspA could only be activated by its
cognate sgRNA (Fig. 4a). This high orthogonality will allow
construction of multiplex and layered CRISPRa with little cross-
talks. We then measured orthogonality between two RNA
aptamer–adaptor pairs, namely, BoxB-λN22plus against MS2-
MCP, in triggering CRISPRa using the same design. Again,
signiﬁcant orthogonality was observed between the aptamer–
adaptor pairs (Fig. 4b, Supplementary Fig. 11).
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Fig. 3 Functional expansion with different σ54-dependent promoters and bEBPs. a Activation of PpspA, PhrpL, PnifH, PnifJ in E. coli. Inducer concentrations used:
For PpspA and PhrpL activation, 1.6 µM AHL (sgRNA), 2.5 ng mL−1 aTc (dCas9), 0.4 mM rhamnose (activator). For PnifH and PnifJ activation, 1.6 µM AHL
(sgRNA), 2.5 ng mL−1 aTc (dCas9), 3.2 mM rhamnose (activator). Statistical difference was determined by a two-tailed Welch’s t test: PpspA, p= 0.0011,
t= 30.69; PhrpL, p= 0.0006, t= 38.34; PnifH (H1), p= 0.0134, t= 8.093; PnifJ (H7), p= 0.0536, t= 4.053; PnifJ (H9), p= 0.0242, t= 6.137. The data of
PnifH and PnifJ are identical to those shown in Fig. 4c. b PnifH and PnifJ activation in K. oxytoca. Inducer concentrations: 2.5 ng mL−1 aTc (dCas9), 3.2 µM AHL
(sgRNA). Statistical difference was determined by a two-tailed t test: PnifH (H1), p < 0.0001, t= 18.85; PnifJ (H7), p < 0.0001, t= 20.73; PnifJ (H9), p=
0.0165, t= 3.976. c The dynamic ranges of hybrid σ54-dependent promoter activation. The asterisk represents the PﬂhDp2 was a predicted σ54-dependent
promoter60. Activator expression was driven by the constitutive promoter BBa_J23106. Inducer concentrations used: 1.6 µM AHL (sgRNA), 2.5 ng mL−1
aTc (dCas9). d Orthogonal activators in E. coli TOP10. Left: Truncated NorRs were fused with a λN22plus adaptor. Right: four activators without the HTH
domain truncations were fused with a λN22plus adaptor and tested. All engineered activators were driven by the promoter BBa_J23106. PpspA-20 was used
for the reporter, which could be activated by sgRNA-LEB2. Inducer concentrations used: 0.025 µM AHL (sgRNA), 2.5 ng mL−1 aTc (dCas9) for ON states.
Statistical difference was determined by a two-tailed t test: NorR (179-504), p < 0.0001, t= 27.54; NorR (188–504), p= 0.0007, t= 9.456; WtsA, p <
0.0001, t= 24.42. Error bars, s.d. (n= 3); a.u., arbitrary units; p value summary: ****p value < 0.0001, 0.0001 < ***p value < 0.001, 0.001 < **p value < 0.01,
0.01 < *p value < 0.05, p value≥ 0.05: n.s. Source data are provided as a Source Data ﬁle
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The locations of UAS can provide an additional layer of
orthogonality. PnifJ and PnifH from the Klebsiella genera are
divergently transcribed and share a common intergenic region
with three UAS for their activator NifA. UAS2 and UAS3 belong
to PnifJ, and UASnifH belongs to PnifH41. We thus hypothesized
that our CRISPRa complex would ﬁnd new and similarly
orthogonal UAS. Nine PAMs that spanned across the intergenic
region of PnifJ and PnifH were tested in E. coli (Fig. 4c). Spacer
H1 strongly activated PnifH but not PnifJ, and spacer H7 and H9
activated PnifJ but not PnifH. The location of these spacers matched
well with the locations of their corresponding native UAS and
proved that our eukaryote-like CRISPRa system could beneﬁt
from orthogonality owing to distinct UAS locations.
PAM expansion and dynamic range optimization by dxCas9.
Although our CRISPRa system allowed us to target wild-type σ54-
dependent promoters, it demanded the presence of an NGG PAM
next to the UAS, which might not be always satisﬁed. A recent
work reported xCas9 as a mutated version of spdCas9 with
ﬂexibilities on PAM choices42. We thus mutated our dCas9 to
dxCas9 based on xCas93.7 and asked if it would allow our
CRISPRa to target UAS with non-canonical PAM.
The dCas9 or dxCas9-mediated CRISPRa could activate PpspA
with the canonical NGG PAM to similar degrees. Contrary to
reported, however, in two cases the dxCas9 could not activate
promoters with NNG PAM (Supplementary Fig. 12a, b). We then
moved on to test NGT PAM, and CRISPRa using dxCas9 gave
remarkable activation (Fig. 5a, Supplementary Fig. 12c). Our goal
was to check if dxCas9 could expand available PAM sites on wild-
type σ54-dependent promoters. Therefore, we treated two TGT
sequences on the wild-type PpspA as PAM, and attempted
CRISPRa on those two UAS using dCas9 or dxCas9. The result
conﬁrmed that our CRISPRa using TGT PAM and dxCas9 was
functional (Fig. 5b), and hence CRISPRa with dxCas9 allowed
more ﬂexible targeting of UAS on different wild-type σ54-
dependent promoters.
In the above experiments, surprisingly, CRISPRa through
dxCas9 showed much lower sensitivities to sgRNA leakiness.
Their sgRNA-dependent dynamic ranges were improved by an
order of magnitude (Fig. 5c). We wondered if this was related to
our engineered sgRNA, which contained BoxB aptamers and thus
set up a CRISPRi experiment using the dxCas9. We observed a
reduction in repression efﬁciencies mirroring that of activation
(Supplementary Fig. 13a–c). It is noteworthy that dxCas9 also
worked poorly with sgRNA that contained two mismatches in the
scaffold (Supplementary Fig. 14). This suggested that dxCas9 has
lower afﬁnities towards its sgRNA or the target DNA and the
change in performance probably did not concern our engineered
sgRNA scaffold.
Serendipitously, the lowered activation background by dxCas9-
based CRISPRa enabled complex circuit designs, which were not
attainable by its dCas9 counterpart. This was showcased in a
cascaded regulation. dxCas9 could be used to build a two-layer
circuit, but when dCas9 was used, background sgRNA expression
was sufﬁciently ampliﬁed by the second layer to yield a constant
ON state (Fig. 5d). Furthermore, a positive feedback loop, which
is self-amplifying in nature and has little tolerance toward input
leakiness, could be built from CRISPRa through dxCas9.
This positive feedback loop was derived from the single-layer
circuit, but with an additional activator generator driven by the
same σ54 promoter as that of the reporter. Therefore, sgRNA
induction should activate not only the reporter but also the extra
activator, which in turn would enhance the CRISPRa system
per se. As a result, the positive feedback loop using dxCas9
rendered the activation response more digital-like and increased
sgRNA-dependent dynamic range from ~ 50 to 200-fold (Fig. 5e).
The same magnitude of fold change was not achieved when
dCas9 was used. dxCas9 could suppress the undesired basal
activation due to sgRNA leakiness and enhance the dynamic
range of the positive feedback loop (Supplementary Fig. 13d).
CRISPRa for multi-gene expression proﬁle screening. CRISPR
activation and repression is often considered as a useful tool to
control metabolic pathway. Many have demonstrated their work
through tuning production of violacein, a purple pigment with
antitrypanosomal and antitumoral activities4,43,44. Yet, most
focused on reproducing known effects of ﬂux redirection in this
pathway to give different terminal products, by tweaking
expression levels of the ﬁve enzymes involved. In an industrial
setting, pathways of interest are often inadequately characterized
with little information for ﬂux optimization. By designing a
CRISPRa-based optimization strategy, we could exhaust a meta-
bolic design space, instead of testing ﬂux redirection by trial-and-
error.
To demonstrate this, genes encoding the ﬁve enzymes (vioA—
vioE) were individually placed downstream of our synthetic PpspA
promoters with orthogonal UAS. A total of ﬁve corresponding
sgRNAs were need for CRISPRa, and three out of the ﬁve sgRNAs
were combinatorially connected to constitutive promoters of
three different strengths, with the remaining two connected to a
strong constitutive promoter. The sgRNA generators were then
mixed and assembled together in a one-step Golden Gate reaction
to yield a sgRNA generator library. The library was thus a
collection of diverse transcription patterns of sgRNAs, which
would project different sets of activation patterns on the ﬁve
genes (Fig. 6a). The sgRNA generator library with other CRISPRa
components and the PpspA driven violacein-producing genes were
then co-transformed into E. coli.
We observed that our transformants from the library had
colonies with different intensities of purple color, which directly
reﬂected the individual differences in violacein production
(Fig. 6b). We then classiﬁed colonies into three bins of violacein
production, and for each bin, retrieved their individual sgRNA
transcription proﬁles by sequencing the sgRNA generator
cassettes from the ﬁve colonies (Fig. 6b). We ended up analyzing
four proﬁles for each bin (see Online Methods). Among the three
genes experiencing different activation patterns, the promoter
strengths for sgRNA activating vioA correlated most with
violacein production (Fig. 6d), suggesting its role as the limiting
factor in the production pathway. It should be noted that the
overall strength of the violacein pathway was heavily inﬂuence by
the level of the dxCas9 and the activator (Supplementary Fig. 15).
These two factors thus served as additional gain tuning knobs for
optimization of the entire pathway.
Next, a new library was created by mixing sgRNA generators
for CRISPRa or CRISPRi, and co-transformed to project more
diverse proﬁles onto the pathway during the proﬁle-scanning
process. This addition of CRISPRi introduced possibilities of
suppressing the basal expressions of the pathway, and so
generated larger differences in violacein production under the
same culture condition (Fig. 6c, Supplementary Fig. 16). The
ability for CRISPRa and CRISPRi to co-regulate is an advantage
of engineering activator onto sgRNA scaffold instead of dxCas9.
In addition, the strength of CRISPRa can be tuned independently
without affecting that of CRISPRi, by modulating the activator
level like tuning the gain knob. This experiment showed potential
for intermediate metabolites and pathway redirection scanning in
future applications. It is worth noting that, our sgRNA generators
already encode all designed transcriptional activation proﬁles, and
therefore it is reusable and optimization of a new pathway would
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not involve any new library construction—the only step necessary
would be the connection of different genes to PpspA with
different UAS.
To further demonstrate the application value of this system, we
design a “rainbow” device to test if the same multi-gRNA
generator library is reusable on a different multi-gene circuit. The
library with mixed sgRNA generators for CRISPRa or CRISPRi
above was co-transformed with a circuit including three
ﬂuorescent protein genes (the rainbow circuit). The ﬂuorescent
protein genes were controlled by the same promoters used to
drive vioA, vioD, vioC in Fig. 6. Therefore, each gene may be
activated to different extents: (1) No activation (the sgRNA
designed for CRISPRi on violacein genes was effectively a
mismatch sgRNA), (2) moderate activation, and (3) strong
activation (Fig. 7a). As expected, strains isolated from the
resulting co-transformed library had a variety of ﬂuorescent
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protein expression proﬁles, which would equate a rainbow color
on a population level if the strains were pooled. Sequencing
results from the strains revealed good correspondences between
ﬂuorescent protein expression proﬁles and the sgRNA generator
units from the multi-gRNA generator (Fig. 7c).
One advantage of our trans-regulated multi-gene control
system is its ability to scale the global expression level of all
target genes proportionally by tuning the activator induction level
—under different CRISPRa efﬁciencies, absolute expression levels
of all ﬂuorescent proteins were altered but the relative expression
proﬁles remained unchanged (Fig. 7b, c).
We also investigated our system’s durability, which is
important for its application in an industry setting. We serially
transferred the culture every 6 hr by diluting the grown culture
into fresh medium and measured ﬂuorescence after 6 hr of
growth. The result showed that all unique rainbow color proﬁles
from individual strains were stable across the four transfers
(Fig. 7d). In addition, there was no detectable metabolic burdens
conferred by our CRISPRa-based expression proﬁle scanning
device, as evinced by the A600 data of this experiment
(Supplementary Fig. 17).
Discussion
In this work, we designed and constructed a CRISPR activation
system based on a eukaryote-like enhancer in bacteria. Owing to
the unique “unlock” mechanism of AAA+ATPase transcrip-
tional activation domain on σ54, these promoters inherently
possess large dynamic ranges that CRISPRa could harness.
Therefore, the CRISPRa output dynamic range was over 1000-
fold (dCas9/activator/sgRNA tuning), and was over 70-fold for
targeting sgRNA versus non-target sgRNA, which exceeded pre-
vious prokaryotic CRISPRa devices. When employed for multi-
channel gene regulation, our CRISPRa system utilizing dxCas9
achieved ~ 50-fold output increase when only sgRNA was varied
(Fig. 5e), and permitted cascade of genes where no other CRIS-
PRa to date has demonstrated.
σ54-dependent promoters play important roles in a variety of
high-value physiological functions in bacteria, such as nitrogen
assimilation and ﬁxation41,45, pathogenicity29,46, host coloniza-
tion47, motility46,47, bioﬁlm formation47, environmental bior-
emediation48, and stress responses45. In principle, our CRISPRa
system can activate any σ54-dependent promoters. Four typical,
high value wild-type σ54-dependent promoters (PpspA/PhrpL/PnifH/
PnifJ) from three species have been successfully activated in E. coli.
PnifH and PnifJ are two key promoters controlling nitrogen ﬁxation
in K. oxytoca and usually require anoxic conditions to be acti-
vated31. Our CRISPRa system in K. oxytoca could activate these
two promoters under aerobic condition, which proved that our
device can bypass host regulation mechanisms on natural σ54-
dependent regulation system in non-model bacteria. Such
context-independent regulation control provides a powerful
means to study σ54-mediated gene regulatory networks in situ,
which has been difﬁcult to achieve by traditional molecular
biology methods.
Similar to activation mechanisms in eukaryotes, our CRISPRa
involves long distance regulation and a ﬂexible DNA loop
structure. Therefore, unlike previous CRISPRa systems based on
the σ70 factor, this CRISPRa tolerates a wide range of UAS
locations (at least 40 bp). It not only accommodates two ortho-
gonal synthetic UAS for input integration on a single promoter,
but also provides large ﬂexibility for PAM selection on wild-type
σ54-dependent promoters. Introduction of dxCas9 into our sys-
tem further enhanced this ﬂexibility by permitting use of non-
canonical PAM.
A CRISPRa-based metabolic pathway screening tool has been
built to optimize a ﬁve-gene pathway of the antitumor chemical
violacein in a single step. The scanning and sequencing results
demonstrated that the outcomes of violacein production could be
explained by transcriptional activation patterns projected onto
the pathway. Most importantly, our tool is reusable—the same
sgRNA generator library could assay different metabolic path-
ways if their enzymes are driven by our PpspA-derived promoters.
A “rainbow” device base on above design was achieved, showing
the excellent stability and durability of the multi-gene expression
proﬁle control. This showed that our design stores multi-gene
expression proﬁle diversities on a universally applicable library,
which can be mass produced conveniently. Our tool should be of
high value to commercial and industrial applications.
There may be some limitations of this system. Our engineered
activator PspFΔHTH::λN22plus was compatible with the σ54-
depedent promoters in both E. coli and K. oxytoca but this
compatibility might be challenged in distantly-related micro-
organisms. In such scenarios, it might be necessary to introduce
the heterologous σ54 factor from E. coli or K. oxytoca, or test other
σ54 activators we developed in this study (engineered PspF, NorR,
WtsA). In addition, when activating a wild-type σ54 promoter, the
available PAM sites may limit the maximum activation efﬁciency
of CRISPRa. Nevertheless, whether the activation efﬁciency is
sufﬁcient depends on the speciﬁc engineering objectives, which
likely vary from one application to another.
Our work also revealed several directions for further study: The
fact that spacer H9 for PnifJ was functional in E. coli (Fig. 3a)
but less functional in K. oxytoca (Fig. 3b) hinted at fundamental
differences in promoter activation processes in the two species.
They may involve differences in DNA bending angles, or other
unknown factors, which warranted additional studies. In addi-
tion, WtsA from E. stewartii, being an orthogonal activator for
CRISPRa in E. coli, might give higher activation efﬁciencies if
engineered by directed evolution or other rational design. For
dynamic range optimization, saturation mutagenesis on the core
sequences of σ54-dependent promoters may improve their
dynamic ranges and output levels. We noted that the expression
ratio between PspF ΔHTH::λN22plus and dCas9 may affect the
Fig. 5 CRISPRa using dxCas9 and non-canonical PAM and its lowered background expression. a Three different NGT PAM were tested by CRISPRa with
dCas9 or dxCas9. The mutated PAM was introduced into the PpspA-LEA3B3, which was targeted by sgRNA-LEA3 in this experiment. Activator expression
was driven by the constitutive promoter BBa_J23106. Inducer concentrations used: 1.6 µM AHL (sgRNA), 1.25 ngmL−1 aTc (dCas9/dxCas9). b Two
spacers with TGT PAM (A1, A2) within the enhancer region of wild-type PpspA were selected as CRISPRa target UAS. Inducer concentrations used: 1.6 µM
AHL (sgRNA), 2.5 ng mL−1 aTc (dCas9/dxCas9), 0.4 mM rhamnose (activator). c The dynamic range optimization effects of dxCas9 on a synthetic
promoter PpspA-LEA1B1. Activator expression was driven by the constitutive promoter BBa_J23106. Inducer concentrations: 1.6 µM AHL (sgRNA), 1.25 ng
mL−1 aTc (dCas9/dxCas9). These data are also shown in Supplementary Fig. 12a. d Two-layer CRISPRa using dCas9 or dxCas9. PpspA-LEA3B3 was used as
the second promoter for the transcription of the sgRNA-LEB1, which activates the third promoter PpspA-LEA1B1. e A positive feedback loop was constructed
using dxCas9 and was compared to a basic activation without feedback. Inducer concentrations used for d and e: 0, 0.006, 0.025, 0.100, 0.400 µM AHL
(sgRNA), 1.25 ngmL−1 aTc (dCas9/dxCas9), 0.2 mM rhamnose (activator). The data of basic activation by CRISPRa is also shown in Supplementary Fig. 14.
Error bars, s.d. (n= 3); a.u., arbitrary units. Source data are provided as a Source Data ﬁle
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formation of activator hexamer through competition, and this
ratio may be further optimized in the future. These further
optimizations should realize the full potential of this tool for
industrial biotechnology and synthetic biology research.
Methods
Strains and growth conditions. Experiments on activator engineering, hetero-
logous activator scanning, and functional tests in different hosts. The experiments
in Fig. 3d, Supplementary Figs. 1f and 2 were performed in the E. coli strain TOP10
as indicated. The experiments in Supplementary Fig. 1e were performed in the E.
coli strain JW3169-1ΔrpoN730::kan from the Keio collection49. Experiments for
PnifJ and PnifH activation in K. oxytoca was performed in the K. oxytoca strain
M5a1. All other assays were performed in E. coli MC1061ΔpspF. E. coli
MC1061ΔpspF was generated via P1 phage transduction using BW25113ΔpspF739::
kan from the Keio collection as the donor strain49.
For growth of E. coli, cells were cultured in Lennox’s Lysogeny Broth (LB-
Lennox) medium (10 g L−1 peptone (EMD Millipore), 5 g L−1 yeast extract (EMD
Millipore), 5 g L−1 NaCl (Fisher Scientiﬁc)) with appropriate antibiotics.
Antibiotics were applied to liquid cultures for assays at ﬁnal concentrations of:
50 µg mL−1 ampicillin (Sigma-Aldrich), 25 µg mL−1 kanamycin (Sigma-Aldrich),
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and 12.5 µg mL−1 chloramphenicol (Sigma-Aldrich). For circuit construction
and selection on agar plates, antibiotics were applied at ﬁnal concentrations of:
100 µgmL−1 ampicillin, 50 µg mL−1 kanamycin, and 25 µgmL−1 chloramphenicol.
For experiments on metabolic pathway proﬁle scanning (Fig. 6, Supplementary
Figs. 15 and 16), the agar plates contained 50 µg mL−1 ampicillin and 25 µg mL−1
kanamycin.
For circuit characterization in E. coli, a single colony of co-transformant
carrying test circuits was picked from an agar plate and suspended in 30 µL of LB
medium with appropriate antibiotics. In total, 5 µL of the cell suspension was then
inoculated into 195 µL of liquid LB medium with antibiotics in a transparent and
ﬂat-bottom 96-well plate (CytoOne). To avoid abnormal growth at the edges of a
plate, outermost wells were not used (ﬁlled by 200 µL of medium). The plates were
cultured at 37 °C, 1000 rpm on a plate shaker (MB100-4A) for 18 hr overnight. The
next day, 2 µL of overnight cultures were added into 198 µL of LB medium with
appropriate antibiotics and inducers (N-(3-Oxohexanoyl)-L-homoserine lactone,
AHL (Sigma-Aldrich), aTc (CAYMAN Chemical), rhamnose (Alfa Aesar),
arabinose (Acros Organics)) on a ﬂat and clear bottom 96-well plate with black
walls (Greiner Bio-one). The dilution factor was 100-fold. The cultures were then
grown for 6 hr at 37 °C, 1000 rpm and then ﬁxed for ﬂow cytometry analysis. All
inducers for liquid culture in this research were prepared as 40 × stock solutions.
Inducers were diluted to 1 × ﬁnal concentrations by adding 5 µL of stock solutions
into a ﬁnal volume of 200 µL of assay volume. There was an exception in metabolic
pathway proﬁle scanning (Fig. 6): rhamnose was prepared as a 200 × solution and
200 µL of the stock solution was added to 40 mL of molten LB agar to reach 1 ×
ﬁnal concentration. The aTc was prepared as a 160 × solution and 250 µL of the
stock solution was added to 40 mL of molten LB agar to reach 1 × ﬁnal
concentration. All experiments were done in triplicates. Three colonies were picked
and cultured separately on different 96-well plates for induction assays.
K. oxytoca M5a1 carries natural ampicillin resistance. 100 µg mL−1 ampicillin
was always added to the agar plate during the co-transformation step, and
50 µg mL−1 ampicillin was used for overnight culture. For plasmid maintenance,
50 µg mL−1 kanamycin and 25 µg mL−1 chloramphenicol were used during the
ﬁnal culturing step (6.5 hr) before ﬁxation (without ampicillin).
All reagents (i.e., antibiotics and inducers) were purchased in powder and were
prepared by dissolving in double distilled water or ethanol followed by ﬁltration
through 0.22 µM syringe ﬁlters (Millipore).
Plasmid circuit construction. Standard molecular biology protocols were used in
this study for circuit constructions. All plasmids and their maps and sequences
have been listed in Supplementary Data 1. The typical composition of the plasmids
used in this study is illustrated in Supplementary Fig. 18. Key primers used in this
study are listed in Supplementary Data 1. Different dCas9 generators, activator
generators and reporter circuits were combined on the BioBrick vector pSB4A350
for assays in E. coli. All sgRNA generators were hosted on a separate and com-
patible vector p15AC. Variants of each component were chosen according to the
speciﬁc needs and details of a particular experiment. Qiaspin Miniprep Kit (Qia-
gen) and Wizard SV Gel and PCR Clean-Up System (Promega) were used in this
study for DNA puriﬁcation.
The dCas9 generator circuit (Supplementary Data 1) was constructed from
pdCas9-bacteria (pdCas9-bacteria was a gift from Stanley Qi, Addgene plasmid #
442491). Two synonymous mutations at R63 (CGT > CGC) and R447 (CGA >
CGT) were introduced into the dCas9 coding DNA sequence (CDS). One
synonymous mutation at S2 (TCT > TCA) was introduced into the TetR CDS, and
a base substitution (+29 site of PtetA, C > G) was introduced between the PtetA
transcription start site and the ribosome-binding site (RBS) for dcas9. The
terminator for the dcas9 operon was changed to a synthetic transcriptional
terminator L3S3P00, and another synthetic terminator L3S3P22 was used for
termination of tetR. The BioBrick RFC10 preﬁx and sufﬁx ﬂanked the dcas9 and
tetR operons so the entire cluster conformed to BioBrick standards. The dxCas9
generator has the same structure with the dxCas9 CDS mutated by overlap PCR
(ProFlex PCR system) (primers provided in Supplementary Data 1). Non-
synonymous mutations encoding E1219V, M694I, E543D, E480K, S409I, R324L,
and A262T from xCas9 version 3.742 were introduced into the dCas9 CDS.
The CDS of PspFΔHTH (1-296 of PspF) was ampliﬁed from the genome of E.
coli TOP10. Through PCR cloning, a BioBrick RBS B0032 was added upstream and
the CDS of λN22plus peptide (MNARTRRRERRAEKQAQWKAAN), along with a
synthetic terminator L3S3P22 were added downstream. The resulting unit was
assembled with either a PrhaB promoter or an Anderson promoter through BioBrick
RFC10 assembly51. Structures and sequences of the Anderson promoters and the
standardized PrhaB are available in Supplementary Data 1. The three versions of
NorR CDS were ampliﬁed from the genome of E. coli TOP10 by PCR (primers
provided in Supplementary Data 1). The RBS B0032, the λN22plus CDS and the
synthetic terminator L3S3P22 were added by PCR cloning. The NifA2 CDS was
ampliﬁed from the genome of K. oxytoca by PCR (primers provided in
Supplementary Data 1), RBS B0032 and terminator L3S3P22 were added by the
primer directly. WtsA::GGGS::λN22plus and ZraR::GGGS::λN22plus, both driven
by the promoter BBa_J2310652 and the RBS B0032, terminated by the L3S3P22
terminator, were synthesized by GeneArt with codons optimized for E. coli. The
engineered HrpRS generator was built from a CRISPRi circuit used in
Supplementary Fig. 13. The λN22plus CDS, the RBS B0032, and the terminator
L3S3P22 were added or modiﬁed by PCR cloning. PspFΔHTH::MCP was
constructed by Gibson Assembly, in which the MCP domain was ampliﬁed from
plasmid pHAGE-EFS-MCP-3XBFPnls which was a gift from Thoru Pederson
(Addgene plasmid # 7538423). A synonymous mutation N86 (AAT > AAC) was
introduced into the CDS of the MCP domain.
The reporter circuits have different promoters. They were all connected to an
identical downstream circuit that contains an insulator RiboJ, the RBS B0030, a
sfGFP CDS with the SsrA degradation tag (ASV). The wild-type PpspA promoter
was synthesized by annealing of oligonucleotides (j5 protocol53). The synthetic
PpspA with different UAS were constructed by PCR-based modiﬁcations on the
UAS regions. The wild-type PhrpL was from our previous work54 and the mutated
PhrpL with a modiﬁed DNA loop, tested in the PspFΔHTH::dCas9 and the CRISPRi
assay, was constructed by reverse PCR. Promoters PnifH and PnifJ were ampliﬁed
from the genome of K. oxytoca M5a1 by PCR (primers in Supplementary Data 1).
All buffer terminators and hybrid promoters were constructed by annealing
oligonucleotides or PCR.
The CRISPRi circuit includes a dCas9 generator, a HrpRS generator (RA32T in
Supplementary Data 1) and a reporter circuit. RBS B0030 and B0032 drive the
translation of hrpR and hrpS, respectively, in a bicistronic operon that is terminated
by the terminator B0015. A mutated PhrpL was used in the reporter circuit. Its core
region was mutated (−2, T > A; −5, G > A; −14, C > T; −21, T > C) to improve its
maximum output. Furthermore, the − 65 & − 66 sites (AA > CC) and the − 90 &
− 91 sites (TA > CC) of this promoter were mutated to create NGG PAM within
the DNA loop region. The 16 bp fragment between the − 24 box and the IHF
region (− 42 to − 63), and the 19 bp fragment from − 70 to − 88 were replaced by
random sequences (Supplementary Data 1) for orthogonal CRISPRi targeting.
For constructions of sgRNA generators, the vector p15AC was ampliﬁed from
pdCas9-bacteria and was ﬂanked by two BbsI sites, which would create sticky ends
for EcoRI and SpeI, respectively. The sgRNA scaffolds with BoxB or MS2 aptamers
were synthesized by annealing oligonucleotides. Each generator contains a Plux2 or
PBAD promoter and a L3S2P21 terminator. Whenever necessary, the spacer
sequence was modiﬁed by PCR cloning. All buffer terminators were inserted 5’ of
sgRNA spacer by PCR cloning. For modularity test of buffer terminators, the
B0062-R terminator was synthesized by annealing oligonucleotides and assembled
with the insulator RiboJ, which was then inserted into sgRNA generator.
Modiﬁcations of the sgRNA scaffold, including introduction of mismatches, were
performed by PCR cloning.
For heterologous expression of CRISPRa in K. oxytoca M5a1, the activator
generator was driven by the promoter BBa_J23106, as PrhaB is non-functional in
Fig. 6 An expression proﬁles scanning tool for metabolic pathway. a Three genes from the violacein production pathway (vioA/vioD/vioC) were chosen as
target genes for expression tuning through CRISPRa. Each sgRNA that targeted its cognate promoter could be driven by one of the three constitutive
promoters with different strengths and the resulting sgRNA generators were mixed to give a multi-sgRNA generator library. b The refactored violacein
pathway was co-transformed with the library and cultured on agar plates for 16 hr with 1 µM rhamnose for activator induction and 0.63 ngmL−1 aTc for
dxCas9 induction (top middle). For negative control (top left), an empty vector was used in place of the sgRNA generator library. For positive control (top
right), the strong constitutive promoter BBa_J2310027 was used to drive expression of all sgRNA. Colonies with visibly different color intensities were
marked by triangles according to their levels of purple color: dark purple (magenta triangles), weak purple (yellow triangles) and white (green triangles).
Sequencing results revealed the transcription patterns of sgRNAs in each colony. The number of purple bricks correlates with strengths of the constitutive
promoters. Images of the same plates are showed in Supplementary Fig. 15. c Pathway optimization by combining CRISPRa and CRISPRi. A new library was
constructed by mixing CRISPRi sgRNA (they targeted the coding regions of the three genes and have no RNA aptamers) under a strong promoter
(BBa_J23100) and CRISPRa sgRNA under BBa_J23100 or a weak promoter (BBa_J23114). The library was used for proﬁle scanning and results were
obtained after 20 hr of culture on agar plates. The images of the same plates are showed in Supplementary Fig. 16. d sgRNA transcription proﬁles were
pooled and analyzed. For each regulated gene, the type of sgRNA and their promoter strengths were plotted against the categorized bins of violacein
production. Each dot represents a connection that maps the violacein production strength to the sgRNA promoter strength for a given target gene
(vioA/vioD/vioC). Source data are provided as a Source Data ﬁle
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K. oxytoca. Circuits on pSB4A3 in E. coli were migrated into pSB4K555 owing to
the endogenous ampicillin resistance of K. oxytoca M5a1. No vector change was
necessary for sgRNA generators.
All constructs in this study were sequenced by Sanger sequencing service
provided by Source Bioscience or MRC PPU DNA sequencing and services.
Metabolic pathway proﬁle scanning. Libraries of tandem sgRNA generators for
transcriptional activation proﬁle scanning were constructed through the following
steps: First, basic sgRNA generator units with three components were built, each
includes an upstream terminator, an Anderson promoter and the sgRNA sequence.
The upstream terminator, with BbsI restriction sites that would create unique
overhangs (Supplementary Data 1), and Anderson promoters with different strength
were made by annealing synthesized oligonucleotides. They were then ligated
upstream to an ampliﬁed and digested sgRNA sequence on the vector pSB1K356
(sgRNA fragments were digested by XbaI and PstI). Second, sgRNA generator units
that contain an identical spacer but different promoters (BBa_J23100 /BBa_J23108
/BBa_J23114)27 were mixed in equimolar ratios to give one set of sgRNA generator
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units. Each set corresponds to a single target gene in which expression would be
tuned. Five sets of sgRNA generator units were then mixed and assembled in a
one-step Golden Gate Assembly system into pSB4A3. It should be noted in Fig. 6,
two out of the ﬁve sets had no variation in promoter choice and only used the
promoter BBa_J23100. Third, the entire Golden Gate Assembly reaction was
transformed into E. coli TOP10 and cultured on an agar plate with ampicillin for
over 20 hr. All colonies on plate (with > 250 colonies, which should cover 27 possible
combinations) were scraped and washed down from the plate and subjected to
plasmid extraction, which yielded a crude library. Fourth, the crude library was
cleaned up by size selection—plasmids were digested by EcoRI and PstI, and then
resolved on an agarose gel by gel electrophoresis. Digested fragments, with sizes that
correspond to the desired assembly product, were excised and self-ligated, which was
then transformed into E. coli TOP10 again. The ﬁnal library was obtained by
scrapping all transformants followed by plasmid extraction. The positive control
sgRNA generator circuit was made by following the same steps with the ﬁve kinds of
sgRNA generator units that only used the promoter BBa_J23100.
The above steps were repeated in generating the CRISPRa+ i proﬁle scanning
library with the following exception: When building a sgRNA generator unit set,
sgRNA generators that contain standard sgRNA scaffold plus spacers that target
CDS of vioA/vioD/vioC were added to the mixture of CRISPRa sgRNA generators.
To construct the violacein production pathway for optimization on metabolic
engineering, the CDS of vioA, vioB, vioE, vioD were ampliﬁed from
pΔ_lvl2_vioABDE57 and the CDS of vioC gene was ampliﬁed from pKMV-VioC
(Addgene plasmid #6534958). The RBS B0030 and ﬁve different terminators were
added to each gene through PCR cloning (L3S2P21 for vioA, L3S2P11 for vioB,
L3S3P22 for vioE, L3S3P21 for vioD, and L3S2P55 for vioC). These translational
units for VioA/B/D/E/C were placed downstream of PpspA-LEA1B1, PpspA-LEA2B2,
PpspA-LEA3B3, PpspA-LEA4B4, and PpspA-LEA5B5, respectively. They were then
assembled with a dxCas9 generator and the PspFΔHTH::λN22 generator on the
vector pSEVA221 (GenBank: JX560327).
Circuits including CRISPRa device, the sgRNA library and the violacein
production pathway were co-transformed into E. coli MC1061ΔpspF, which were
then spread on LB-Lennox agar plates with ampicillin, kanamycin, aTc and
rhamnose. Three kinds of plates with different inducer concentrations were made
and used for culturing co-transformants: (1) 5 µM rhamnose+ 0.63 ng mL−1 aTc,
(2) 1 µM rhamnose+ 0.63 ng mL−1 aTc, and (3) 0 µM rhamnose+ 0.63 ng mL−1
aTc. All plates were incubated at 37 °C overnight. Pictures of the agar plates with
colonies were then taken by a digital SONY NEX-5R camera under normal lighting
conditions in a laboratory after incubation durations of 14, 16, 18, and 20 hr. For
post-acquisition processing, brightness and contrast of photos were adjusted in
Photoshop CS3. Each photo was then scaled using a ﬁve pence coin that was taken
in the same shot so that colony sizes across different plates would be comparable.
All scaled photos were cropped to areas of interest. Colonies to be picked and
sequenced were selected from an area of interest at 16 (CRISPRa) or 20 (CRISPRa
+ i) hr post-incubation and their positions were recorded. They were then picked
and inoculated after the last photograph time point has passed.
For the expression proﬁle test on the rainbow device, the above CRISPRa+ i
library was co-transformed with the rainbow circuit with the same steps. The agar
plate did not include inducers. Colonies were picked and suspended in 30 µL of LB
medium. For each strain, 5 µL of cell suspension was added into 195 µL LB medium
with ampicillin and kanamycin for overnight (18 hr) liquid culture in a 96-well plate,
which then was diluted 100-fold into fresh medium with antibiotics and inducers
and grown under 37 °C, 1000 rpm for 6 hr for data collection. Part of the cultured
strains (LY1–LY9) were serially transferred every 6 hr (2 µL of grown culture into
198 µL of fresh medium) with antibiotics and inducers up to 24 hr. The plate was
read every 6 hr after each transfer by a plate reader (BMG FLUOstar ﬂuorometry).
Gene expression assays. For all the experiments except rainbow device, only one
standardized reporter sfGFP was used to characterize promoter outputs in this
work. All ﬂuorescence data (except the rainbow device and the experiment of
Supplementary Fig. 1f) was measured in an Attune NxT Flow Cytometer (equipped
with Attune NxT Autosampler). For ﬁxation, 2 µL of cultured bacteria was added
to 198 µL 1 × phosphate-buffered saline (K813-500ML, VWR) in a 96-well U-
bottom plate (Thermo Fisher Scientiﬁc) with 1 mgmL−1 kanamycin and the
samples were stored in 4 °C for at least 1 hr before data acquisition.
Fixed samples were read by the Flow Cytometer, equipped with 488 nm
excitation laser and 530/30 nm emission ﬁlter for green ﬂuorescence
measurements. For each sample reading, the cytometer was instructed to wait for 4
s before recording single cell ﬂuorescence, and at least 10,000 gated events were
recorded using a ﬂow rate of 25 µL min−1. Flow cytometry data were analyzed by
FlowJo (v7.6.1) and appropriate forward and side scatter gates were applied to all
samples for each experiment. The geometric means of ﬂuorescence were taken as
population ﬂuorescence. For the UAS shift test in Fig. 2a, median values were taken
as population ﬂuorescence to avoid impact of extreme values. For rainbow device,
we used a plate reader (BMG FLUOstar ﬂuorometry) to collect ﬂuorescence and
A600 data, and calculate ﬂuorescence/A600.
For the measurement of expression proﬁles of the rainbow strains and the
experiment of Supplementary Fig. 1f, data were acquired from a plate reader
equipped with a 405–10 nm excitation laser and a 460 nm emission ﬁlter for blue
ﬂuorescence measurements (Gain 1372), a 485 nm excitation laser and a 520 nm
emission ﬁlter for green ﬂuorescence measurements (Gain 1263 for the rainbow
strains; Gain 700 for the experiment of Supplementary Fig. 1f), and a 584 nm
excitation laser and a 620–10 nm emission ﬁlter for red ﬂuorescence measurements
(Gain 2240).
Absorbance (A600) assays. Cell densities, measured by absorbance (A600), were
used as a proxy of cellular burden. A600 values were measured using a plate reader
(BMG FLUOstar ﬂuorometry). To set up blanks for measurements, 200 µL of
liquid LB medium was added to a blank well without inoculation, in which the
volumes to be occupied by inducers were ﬁlled with water. This step would be done
at the same time when cells were diluted to give assay cultures. Therefore, effects of
evaporation and inducer dilution should apply equally to both the blanks and the
cell cultures. The A600 values were processed and analyzed in Microsoft Excel 2013.
Quantitative RT-PCR. The strains were cultured in 200 µL Lennox’s LB medium
with appropriate antibiotics under 37 °C 1000 rpm overnight (16–18 hr). They were
then diluted 100-fold into 1 mL fresh medium with appropriate antibiotics and
inducers in a 96-well deep-well plate (Starlab). The diluted culture was incubated
under 37 °C 1000 rpm for 6 hr. Then the total RNA was extracted by the Aurum™
Total RNA Mini Kit (Bio-Rad). The RQ1 RNase-Free DNase (Promega) was
employed to digest the residual genomic DNA, and the iScript™ Reverse Tran-
scription Supermix (Bio-Rad) was used to generate cDNA in 10 µL reaction sys-
tems through reverse transcription. The iTaq™ Universal SYBR® Green Supermix
was used for qPCR in 10 µL reaction systems with 60 °C as the annealing tem-
perature, and 30 s were set as the extension time. The housekeeping gene rho was
used as the reference gene. All the genes in RT-qPCR experiments were isolated
from the genome of E. coli and were cloned on a high copy-number plasmid
pSB1K3 as the standard sample for standard curve generation. The qPCR reactions
were run on a LightCycler 480 qPCR system (Roche). The relative expression levels
of target genes were calculated using the LightCycler 480 software and Excel 2013
by the Pfafﬂ method (normalized by the reference gene rho). The primers for gene
isolation and qPCR are provided in Supplementary Data 1.
Calculation of ﬂuorescence intensities. The RT-qPCR experiment includes 6
biological repeats. All attempts at replication were successful. All geometric mean
of ﬂuorescence of a population were corrected by background ﬂuorescence of cells
with suitable empty plasmids grown in identical conditions but without inducers.
Corrected ﬂuorescence values were then averaged in GraphPad Prism 7.05 (except
rainbow device) to give the medians or means with standard deviations (SD),
Fig. 7 The reusability of the multi-gRNA generator library, and the stability of expression proﬁles. a The multi-gRNA generator library (with sgRNA for
CRISPRa and CRISPRi) we used for violacein pathway could be used on other target circuits. The CRISPRa device can project the transcription proﬁles of
each multi-gRNA generators to target circuits and generate a variety of gene expression pattern. Three different ﬂuorescent protein genes were used as
reporters in this experiment. The genes sfGFP, mCherry and mTagBFP2 were controlled by the same artiﬁcial σ54 promoters for vioA, vioD, vioC respectively.
Each gene may be activated by CRISPRa to different extents: (1) No activation (the sgRNA designed for CRISPRi on violacein genes was effectively a
mismatch sgRNA), (2) moderate activation, and (3) strong activation. b Absolute ﬂuorescence/A600 values of the three reporters detected from each
strain. Left: values from BFP channel; Middle: GFP; Right, RFP. For high-induction condition, 1.25 ng mL−1 aTc (dxCas9), 0.4 mM rhamnose (activator) were
used. For low induction condition, 1.25 ngmL−1 aTc, 0.1 mM rhamnose were used. 1.25 ngmL−1 aTc, 0 mM rhamnose were used for OFF state. The PC strain
was a positive control strain that carried a multi-gRNA generator with strong promoter BBa_J23100 for all sgRNA for CRISPRa. c PC strain-normalized
ﬂuorescence/A600 values, which shows the relative proportions of the three ﬂuorescent proteins in each strain under different induction conditions. Legend
for colored circles beneath the data bars: dark color, the sgRNA transcription is driven by strong promoter; light color, driven by weak promoter; white
color, mismatch sgRNA. Information for colored circles come from the sequencing results of each strain. d Serial transfers (100-fold every 6 hr) and
induced growth up to 24 hr. 1.25 ng mL−1 aTc (dxCas9), 0.4 mM rhamnose (activator) were used in this test. The bar chart shows PC strain-normalized
ﬂuorescence/A600 values. Error bars, s.d. (n= 3); a.u., arbitrary units. Source data are provided as a Source Data ﬁle
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which were used for plotting graphs. There were two exceptions: the data for heat
maps (Fig. 4a, b) and the rainbow device (Fig. 7): For heat maps, means were
calculated in Microsoft Excel 2013 and then imported into GraphPad Prism for
plotting the heat maps. Two-tailed t tests were performed using GraphPad Prism
7.05. For the rainbow device and the experiment of Supplementary Fig. 1f, the
mean of ﬂuorescence values and OD values were corrected by a blank negative
control (with corresponding volumes of medium and with water replacing indu-
cers). The ﬂuorescence/A600 for each well was then calculated. The ﬂuorescence/A600
value was corrected by that of a ﬂuorescence-free strain. All the calculation
was done in Microsoft Excel 2013. Error calculation follows the propagation
of error.
Calculation of cell densities (absorbance A600). All A600 values were corrected
by blank absorbance of liquid LB medium without cells. Corrected A600 values were
then averaged in GraphPad Prism 7.05 to give means and standard deviations (SD),
which were used for plotting graphs.
Calculation of dynamic ranges. For all dynamic range calculations, the means and
standard deviations (SD) of geometric mean ﬂuorescence from all samples were
ﬁrst calculated by the built-in formulae AVERAGE and STDEV in Microsoft Excel
2013. The calculated mean was then corrected by the mean of background ﬂuor-
escence of cells. Error propagation was calculated by the following formula:
SDcor ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
SDðxÞ2 þ SDðncÞ2
q
ð1Þ
SDcor, standard deviation of corrected mean; SD (x), SD of the three geometric
mean ﬂuorescence values from particular sample x; SD (nc), SD of that from
negative control sample.
The dynamic range DR was calculated by the corrected mean value of
ﬂuorescence:
DR ¼ Fluo onð Þ  Fluo offð Þð Þ=Fluoðoff Þ ð2Þ
Fluo (on), the corrected means of three geometric mean ﬂuorescence values
from samples under on state; Fluo (off), the corrected means of three geometric
mean ﬂuorescence values from samples under off state; DR, dynamic range.
The standard deviation of DR (SD (DR)) was calculated by the uncertainty
propagation formula:
SD on offð Þ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
SDcorðonÞ2 þ SDcorðoff Þ2
q
ð3Þ
SD DRð Þ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
SDðon off Þ= Fluo onð Þ  Fluoðoff Þð Þð 2þ SDcorðoff Þ=Fluoðoff Þð Þ2
q
´DR ð4Þ
The ﬁnal mean (DR) and standard deviation (SD (DR)) values were imported
into GraphPad Prism 7.05 for plotting graphs.
Sequencing analysis of metabolic activation proﬁle scanning. For CRISPRa-
based metabolic activation proﬁle scanning, and for each bin of purple color
intensity, ﬁve colonies were identiﬁed and marked after 16 hr of growth on agar
plates. The same was applied to CRISPRa+i based proﬁle scanning, but colonies
were identiﬁed and marked after 20 hr of growth. For each scan, those previously
marked colonies were picked and each was inoculated into 10 mL of LB medium
with 100 µg mL−1 ampicillin in a 30 mL universal container (Starlab). After
overnight culture at 37 °C, 160 rpm, plasmids were extracted from each culture and
were sequenced by Sanger sequencing (Source BioScience). The sequencing results
were aligned to known sequences of sgRNA generators by the software SnapGene
3.2.1 to recover the identities of the promoters of the sgRNA generator, or the
identity of the CRISPRi sgRNA. Results that failed to give proper reads or indicated
mixed clones were excluded from downstream analysis. For fair comparison, each
bin used the same number of colonies for analysis.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The previously constructed plasmids pdCas9-bacteria (Addgene #44249), pHAGE-EFS-
MCP-3XBFPnls (Addgene #75384), and pKMV-VioC (Addgene #65349) used in this
study are available from Addgene. Key plasmids constructed in this study are available
from Addgene at https://www.addgene.org/Baojun_Wang/. All other data and materials
from this work are available from the corresponding author upon reasonable request.
The source data underlying Figs. 1c–e, 2a–d, 3a–d, 4a–c, 5a–e, 6b, c, and 7a–d, and
Supplementary Figs 1a–f, 2a, b, 3a, b, 4a, b, 5a–f, 6a, b, 7a–c, 8a, b, 9a, b, 10a, b, 11a, b,
12a–c, 13a–d, 14–17 are provided as a Source Data ﬁle.
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